420 with CNW — Marijuana Firms Register Mixed Results from Foray into Twitter Adverts

Angel Ferrer, the head marketing executive of Hemper Co., created a Twitter profile and uploaded an advertisement for the company’s products on the market, stocked with a range of marijuana accessories, in February, when Twitter allowed cannabis ads. The account was deleted by Twitter shortly thereafter. Ferrer said he would keep learning how to deal with Twitter regardless of the disabling of his initial ad.

The first big digital media site to permit marijuana advertising was Twitter, which has its headquarters in San Francisco. But there are several limitations for marketers, as companies such as Hemper are discovering.

Cannabis businesses must first obtain platform approval and adhere to other guidelines, such as having a license in areas where they conduct business and limiting their customer base to individuals older than 21. Twitter forbids the advertising of drugs and drug-related items but allows businesses to advertise their products and services. Twitter has provided a six-week promotional incentive for marijuana brands to boost marijuana ad sales.

The business announced that it will meet new advertising expenditures of up to $250,000 on a single-transaction basis. The limited-time deal is valid through March 31, 2023.

Kate Lynch, the marketing vice president for Curaleaf Holdings, expressed excitement about having a new platform to advertise the business’s goods and immediately began a Twitter advertising strategy. The corporation advertised for a fortnight to see if it would drive traffic to its website. According to Lynch, the company will shortly update the advertisement with fresh content.

The company attempted to demonstrate which burned more quickly in a video advertisement that was not accepted by Twitter: a normal marijuana roll or a marijuana cigar rolled using one of the company’s products.

Additional social media companies are likely to emulate Twitter’s example, according to several industry analysts. Will cannabis businesses, however, make a profit from their expenditures? Many people assume that sites such as Google and Facebook, which are publicly accessible companies, won’t allow cannabis ads before the substance is made legal on a federal level.

Recent changes to Google’s ad network have reduced prohibitions on cannabis and cannabidiol marketing in a few countries, but a majority of other marijuana promotion is still not allowed.

While businesses such as Purple Rose and Curaleaf can track how many website clicks their Twitter advertising generated, they are unable to discern whether those clicks were translating into actual sales.

For companies such as India Globalization Capital Inc. (NYSE American: IGC), the advertising woes faced by marijuana companies aren’t an issue because companies taking their products through the FDA-approval process follow a different path to market.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Foundation for Improving Effectiveness of Lipophilic Drugs, APIs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is positioned for opportunity with its patented DehydraTECH(TM) technology and its wide-reaching potential. “Lexaria’s DehydraTECH is designed to formulate and deliver lipophilic (fat-soluble) drugs and active pharmaceutical ingredients (‘APIs’). DehydraTECH increases the effectiveness of and improves the way APIs enter the bloodstream. The benefits of consuming a DehydraTECH-enabled drug or product include: speed up in delivery time; increased bioavailability; increased brain absorption; improved drug potency; and reduction in drug administration costs. Animal studies of DehydraTECH have demonstrated the ability to elevate the quantity of the drug delivered across the blood-brain barrier by as much as 1,900%,” a recent article reads. “Lexaria’s technology is best thought of as a foundation that providers of drugs and consumer supplements can utilize to improve the effectiveness of their existing or planned new offerings. DehydraTECH is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, and over-the-counter capsules, pills, tablets, or oral suspensions.”

To view the full article, visit https://cnw.fm/3oeyM

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and many patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Prime Harvest Inc. Launches Weed 4 The People Reg A+ Offering to Fund Cannabis Retail and Delivery Expansion Across California

Prime Harvest launched Reg A+ offering, Weed 4 The People, which enables public to invest for as little as $4.20 per share
Company aims to raise $42M to fund expansion of JAXX Cannabis, flagship store and delivery platform
Company achievements include 976% revenue growth from 2019-2022, 395% unique customer growth, 60+ brand partners
Company aims to open 20++ locations across California within five years, recently received approval recommendation for conditional use permit to open retail cannabis outlet in the City of San Diego

Prime Harvest, a tech-focused legal cannabis enterprise and parent company to SoCal’s premier dispensary JAXX Cannabis, recently launched Weed-4-The-People – the company’s Reg A+ offering that allows the public to own a piece of the company for as little as $4.20 per share at a minimum of 100 shares.

Prime Harvest aims to raise upwards of $42M to fund the expansion of JAXX Cannabis, the company’s flagship store, and delivery platform. Options for potential investors range from $420 to $50,000+, with rewards that include equity stake in the company, and in store benefits including instant rebates, cashback incentives, Jaxx tasting room access, bonus shares, and more.

“Weed-4-The-People is a different type of stock offering; an offering where every single dollar you invest goes toward the acquisition of licensed assets, toward the development our direct-to-consumer mobile app, and the expansion of state-wide delivery,” stated Prime Harvest Founder Duane Alexander in a note on the Reg A+ offering website.

Prime Harvest has been active in the San Diego cannabis space since its inception as a local producer in 2017. The company has since grown to include 60+ brand partners, including iconic brands like Jeeters, STIIIZY, Lime Cannabis Co., West Coast Cure, and Grizzly Peak.

The company’s objective is to continue the development of its upcoming first-in-class delivery service mobile app which promises to strengthen the commercial cannabis pipeline while offering consumers a personalized, data-driven experience. According to Reg A+ offering website, company revenue grew by 976% from 2019-2022, while annual customer growth increased by $696 and unique customer growth expanded by 395%.

Prime Harvest aims to open 20+ locations across California within the next five years. The company recently received an approval recommendation from the San Diego Planning Group for a conditional use permit to open a retail cannabis outlet in the City of San Diego (https://cnw.fm/hCK6u). Unlike previous attempts from different business entities, Prime Harvest’s application took a positive turn due to noteworthy support by the local community during the public hearings process.

Prime Harvest continues to grow its footprint in California by investing in the growth and scale of current licensed assets, focusing on acquisition, compliance management, and direct-to-consumer operations. With an experienced leadership team, a solid business foundation, and a winning track record, the company is strongly positioned to lead California’s rapidly growing cannabis sector.

For more information on Prime Harvest’s Reg A+ offering, visit www.weed4thepeople.com.

For more information, visit the company’s website at www.PrimeHarvestInc.com.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest are available in the company’s newsroom at https://cnw.fm/PRIME

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Confident that 2023 will be Lexaria’s Best Year Ever

Chris Bunka, Lexaria’s CEO, remains confident that 2023 will be Lexaria’s best year ever and has expressed his optimism that the company will continue to build its client base and increase its cash flows as the year progresses
In his 2023 letter to stakeholders, the CEO expressed his satisfaction given that the company had delivered on a statement that he made the previous year, lauding his team for meeting objectives that Lexaria had set out to achieve in the 2022 calendar year
Through the help of his team, Bunka is committed to making Lexaria one of the top drug delivery performers in the biotech/pharmaceutical world, starting with the launch of its FDA-registered IND program to investigate its patented DehydraTECH(TM)-processed CBD for the potential treatment of hypertension

Back at the start of the 2022 calendar year, Chris Bunka, the CEO of Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, released his annual letter to all stakeholders. Of note was his emphasis on the company’s initiatives to have multiple choices in how it was funded, specifically trying to position Lexaria for non-dilutive injections of capital through strategic partners and other commercial relationships (https://cnw.fm/icp9D).

In his 2023 letter, Bunka expressed his satisfaction and pleasure, given that the company delivered on the statement he made the previous year, pointing to his team for delivering objectives that Lexaria had set out to achieve in the 2022 calendar year.

Under the able leadership of John Docherty, Lexaria’s President and Director, as well as Gregory Downey, the Chief Financial Officer (“CFO”), the company has built on the progress made in 2022 to begin the transition toward a more commercial focus.

Lexaria was granted new patents in 2022, bringing its total to 28 granted patents worldwide across the United States, Canada, Mexico, Australia, Japan, India, and the European Union. The management expects to be awarded additional patents in the 2023 calendar year, even though it has already achieved considerable intellectual property protection through its existing patent portfolio.

Importantly, with its current positioning, Lexaria is seen as being able to fully operate through nearly all of 2023 without raising additional capital:

“In fact, we’ve done such a great job of preserving capital that we could survive through nearly all of 2023 without needing to raise additional capital, if we cut back a little on our R&D spending,” noted Bunka. “However, as we prefer to keep advancing our applied R&D at a rapid pace as we can, we are also continuing to pursue capital-strengthening possibilities that do not involve the issuance of any equity,” he added.

Going forward in 2023, Lexaria looks to launch its FDA-registered Investigational New Drug (“IND”) program to formally investigate its patented DehydraTECH(TM)-processed CBD for hypertension. The company also seeks commercial relationships this year, even as its R&D progresses. Bunka has also shared the possibility of additional investigations in 2023 related to DehydraTECH-CBD or other pharmaceutical areas of interest.

With the learnings from the previous year, Bunka is confident that 2023 will be Lexaria’s best year ever. With the company enjoying more successes than failures, its management hopes it will continue to build its client base and increase its cash flows as the year progresses.

“It is my goal for 2023 to make Lexaria Bioscience one of the top drug delivery performers in the biotech/pharmaceutical world as we continue to prove the validity of our technology, and really begin our efforts to deliver financial rewards to you, our owners,” noted Bunka.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — SD Governor Vetoes Proposed Law to Raise Hemp THC Cap

South Dakota Governor Kristi Noem has vetoed a bill that sought to increase THC levels in industrial hemp and its derivatives. Industrial hemp was legalized in 2018 after Congress approved the Farm Bill and allowed farmers across the country to cultivate, process and sell industrial hemp with less than 0.3% THC in state and tribal programs.

THC (delta-9 tetrahydrocannabinol) is the main chemical agent in marijuana, and it produces the plant’s infamous psychoactive effects. But while marijuana contains high enough levels of THC that the chemical can cause mind-bending effects, industrial hemp has very little THC and no psychoactive effects.

Retailers across the country can now carry and sell hemp products as long as they contain less than 0.3% THC. According to Governor Noem, the bill to increase THC limits in industrial hemp would “jeopardize the effectiveness and safety” of South Dakota’s industrial hemp sector. She said that the measure would conflict with federal law that sets THC levels in hemp to below 0.3% while making it impossible for marijuana products, which usually contain well over 0.3% THC, to be classified as hemp products.

The governor said in a public statement that passing bill HB 1209 would go against the “clearly expressed will of the people,” referring to state residents who rejected a recreational cannabis measure in the 2022 ballot. Bill HB 1209 was sponsored by Representative Oren Lesmeister and would have increased THC limits in industrial hemp to 5%. However, Governor Noem noted that doing so would undermine the state’s enforcement of drug laws and jeopardize its hemp program.

South Dakota currently allows for THC levels of up to 1% for hemp plants that are currently in the processing stage. Bill sponsor Lesmeister said that while these high levels are temporary, they are inevitable during processing when highly concentrated oils and cannabinoids are being extracted from the plant matter. He added that as hemp product processors aren’t regulated by the federal market, states with hemp programs often overlook higher-than-0.3 % THC concentrations during processing.

His measure would make it so that THC levels of up to 5% were allowed during processing, similar to regulations in New York and Colorado. Lesmeister explained that the current 1% upper limit was a compromise, but that processors regularly exceed 1% THC levels in processing before THC levels drop to below 0.3% THC once the final product is complete.

This spike prevents licensed processors from accessing crop insurance and similar safety nets that are accessible to other crop markets.

Until the disconnect between marijuana policies at the federal level are updated to be in sync with the reality at state level, many budding entities such as Advanced Container Technologies Inc. (OTC: ACTX) may walk a tightrope trying to serve companies within jurisdictions where marijuana is permitted for either therapeutic or recreational use.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Major Association in Alcohol Industry Backs Federal Cannabis Legalization

A major industry group representing the alcohol industry urged lawmakers to federally legalize adult-use marijuana in a letter sent to congressional leaders on Wednesday. According to the WSWA, the current disparity between federal and state law not only has negative effects on both cannabis users and nonusers, but it will also have prolonged effects on public safety and health.

In its letter, the association emphasized two major points: first, cannabis regulation could be modeled after the current alcohol system, and second, piecemeal cannabis reform is unworkable, so legislators should take a comprehensive approach to the problem.

Additionally, the letter emphasizes the need for states to maintain their independence in deciding whether or not to legalize marijuana within their territory. Moreover, it endorses the proposal for the national government to permit interstate cannabis trade, which is a view that is broadly shared by lawmakers and business leaders in the majority of states.

The WSWA cited a 2021 policy brief that outlines the regulatory priorities it believes legislators should consult as they work to find a framework for legalization. According to the policy brief, legislators should borrow experiences from alcohol regulations and guidelines to create a marijuana regulatory framework that fosters public safety, innovation and industry competition.

WSWA outlined four major guidelines for federal control over a supply chain for marijuana for adult use: the federal licensing of marijuana growers, importers, testing labs and distributors; the control and approval of marijuana products; the effective and efficient collection of excise tax at the federal level; and the effective implementation of strategies to promote public safety.

In its policy brief’s conclusion, WSWA — which in 2018 spoke out in favor of states legalizing marijuana — explained its decision to offer advice on federal marijuana reform. According to the report, a secure and prosperous market has since emerged after the end of alcohol prohibition, one that meets the requirements of consumers and regulators alike.

Cannabis regulation and legalization bills at the federal level have twice passed through the House but failed in the Senate due to the latter’s failure to pass comprehensive reform. WSWA’s involvement, according to proponents of legalization, could strengthen efforts to persuade lawmakers to take the matter more seriously.

A significant distinction between the WSWA’s proposal and that of Chuck Schumer, Senate Majority Leader, is the allocation of regulatory responsibility. Advocates have expressed concern about the Senate proposal’s deference to the FDA, and it is likely that many stakeholders would find WSWA’s position on having TTB handle basic oversight to be more agreeable.

That jostling aside, a less controversial path is being explored by various enterprises, such as India Globalization Capital Inc. (NYSE American: IGC), in which efforts are being deployed to produce FDA-approved medicines from cannabis constituents such as THC for several indications.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Maryland Follows Growing Nationwide Trend, Opens First Marijuana Consumption Lounge

Maryland has officially joined a small but growing group of U.S. states with operational marijuana consumption lounges. Launched in Burtonsville, Ceylon House is the first marijuana consumption lounge in Maryland that allows adults to gather and smoke cannabis outside of their homes.

The facility will only serve medical marijuana patients for the moment, and staff will check customer licenses at the door before letting them in. At the moment, Ceylon House currently operates in a sort of grey area because Maryland law hasn’t legalized consumption lounges, but it hasn’t outlawed them either.

One of the most contentious issues in the nascent marijuana cannabis has been the issue of public consumption. While dozens of states now have recreational and medical cannabis programs, consuming the drug in public is strictly forbidden in all states, and people are required to consume cannabis in private residences. However, this locks out a large portion of customers known as “cannabis tourists” who travel from states that may not have legal cannabis markets to states that allow recreational cannabis use.

Public consumption lounges were presented as a solution to this issue because they would provide customers with a semipublic place to consume cannabis without exposing passers-by to secondhand smoke.

Customers pay $25 to get into Ceylon House and smoke medical marijuana. Owner Venushki “Venus” Hemachandra notes that the county has put plenty of restrictions on the consumption lounge, such as requirements for air quality. The establishment also isn’t allowed to sell drinks, food or cannabis, but it can rent and sell bongs and other cannabis-related paraphernalia to customers.

Adults in Maryland recently voted in favor of a measure to legalize recreational cannabis, and the state has had a medical marijuana market for close to a decade now. The state is also currently working on policies and rules for a new recreational marijuana program, and we can expect the restrictions on who can use marijuana consumption lounges to loosen over time.

The cannabis measure circulating in the state legislature would allow for the establishment of 15 cannabis-consumption cafes in Maryland. Maryland joins a group of six states that have legalized marijuana consumption lounges for either medical or recreational cannabis users.

Colorado, which is home to one of the largest cannabis markets in the country and attracts plenty of cannabis tourists per year, was among the first states to allow consumption cafes to give cannabis tourists a place to consume cannabis products.

The growing trend of consumption lounges could boost cannabis sales, and that in turn may increase the demand for various products and cultivation equipment such as those made by Advanced Container Technologies Inc. (OTC: ACTX) in a bid to meet the thriving customer base.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Swiss Capital to Run Pilot Program of Marijuana Legalization

In an experiment to evaluate the financial and social advantages of controlling marijuana, the Swiss regime has authorized its intentions to end the criminalization of the trade and use of marijuana in Zurich. Beginning this summer, some 2,100 Zurich residents will be allowed to purchase the medicine in predetermined amounts for individual use from drugstores, social clubs and medical facilities throughout the city.

As a requirement for the research carried out in partnership with Zurich University, those participating will respond to survey questions every six months regarding their consumption patterns and health impacts. The experiment’s ultimate goal is to ascertain the circumstances wherein Switzerland’s permission for marijuana use can be consistent with enhancing private and public wellness and safety, according to the leaders of the study.

In the following year, the evidence gathered from the experiment will be made public in bits and pieces. The goal is to gather solid real-world data that will aid in the creation of new marijuana regulations.

This decision was made at a time when other regions of Europe are reviewing their cannabis laws in reaction to broader shifts in worldwide drug laws. In the weeks to come, Germany, the continent’s largest economy, anticipates introducing a bill legalizing cannabis use and sales, making it the first European Union nation to allow for the drug’s widespread commercial sale. The Czech Republic and nearby Luxembourg also recently introduced measures to allow marijuana for adult use. Small quantities of the substance for personal use are not considered illegal in Spain, Italy and Australia.

In 2021, Malta, the smallest EU country, became the first nation in the union to legalize marijuana for personal use and to allow the creation of individual marijuana clubs where users can cultivate and exchange the drug. For the past 10 years, efforts have been made to end the prohibition of the substance in Uruguay, Canada and most recently, Thailand.

Residents of Zurich are welcome to register if they’re willing to participate in the experiment. Participants must be active marijuana users who are of consenting age, do not have any chronic medical issues, and aren’t fully engaged as commercial drivers.

Primary-care surveys indicate that roughly one-third of consenting Swiss citizens have reportedly tried marijuana. Approximately 13,000 citizens of Zurich are frequent users.

In the upcoming months, more investigations are also anticipated in Bern, Thun, Basel, Olten, Geneva, Winterthur and Biel, with support from the public and academic sectors.

While these efforts abroad are ongoing to test the waters of cannabis legalization, several companies in the United States, such as India Globalization Capital Inc. (NYSE American: IGC), are doing their own research aimed at developing a number of formulations that are effective against health conditions such as chronic pain and others.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

NECANN Vermont Cannabis & Hemp Convention to Increase ROI in the Cannabis Industry

Cannabis entrepreneurs, executives, and marketers are invited to attend the NECANN Vermont Cannabis & Hemp Convention to be held from May 6-7, 2023 at Essex Junction, Burlington, VT.

The fast-paced, energetic nature of cannabis and psychedelic events is prominent. NECANN specializes in creating resource hubs for the fast-expanding cannabis industry. Events where entrepreneurs, educators, businesses, advocates, investors, patients, and consumers can learn, connect, and thrive.

NECANN Vermont Cannabis & Hemp Convention will focus on advanced businesses and products serving the cannabis industry and its agricultural, financial, medicinal, and lifestyle aspects. A great substitute to the generic national canna-convention franchises, NECANN Vermont Cannabis & Hemp Convention is focused on each local market’s opportunities and needs. It is the largest convention focused solely on the Vermont market.

The largest comprehensive cannabis convention will feature local government representatives and global industry leaders from across the region presenting discussions and taking part in panel discussions on the convention stage. This multifaceted convention offers a platform for big cannabis business deals to be simplified while providing attendees an opportunity to learn about the cannabis industry.

Insights into Global Cannabis Industry

NECANN takes a collaborative approach to Vermont Cannabis & Hemp Convention that has resulted in regularly high ROI for exhibitors, attendees, sponsors, and the local cannabis market as a whole, expediting growth for all.

Vermont became the 11th state to legalize adult-use cannabis sales, and the second state to do it through regulation instead of a voter initiative. The legislature took additional steps in 2021 in the form of a bill that stiffens social equity provisions by demanding regulators eliminate or reduce licensing costs for applicants who have been deleteriously impacted by the implementation of cannabis laws.

Burlington has a brand-new cannabis market just waiting to blossom. NECANN is proud to be a part of the expansion of such a magnificent community. NECANN Vermont Cannabis & Hemp Convention will help evolving cannabis markets succeed and grow This much-awaited event is expected to attract the largest number of MMJ, local Hemp, and Cannabis industry specialists in the market.

Attendees will get an opportunity to learn about the cannabis laws, how to get a grower’s permit, what fertilizers and tools are required to grow the best crops, an array of health benefits of cannabis, the massive business opportunities the cannabis industry has to offer, and more.

To learn more, please visit https://cnw.fm/1AAui.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — How Technology Companies Help Cannabis Retailers Access Payment Solutions

Cannabis retail is booming in the United States, and by 2024, it’s predicted that sales will reach an estimate $31.8 billion. This massive growth is partly driven by cannatech businesses that take the lead on technological advancements. One such company is Treez, which enables in-person and online sales while providing dispensaries with a variety of digital payment options that boost customer satisfaction and sales.

The Safe Banking Bill and federal legalization of cannabis are both making little progress in Congress, despite state-level legalization being on the rise. Since banks and most credit card companies are reluctant to be involved with cannabis businesses due to the uncertainty surrounding federal marijuana legalization, many of them are forced to work as cash-only operations.

Cannatech businesses have seemingly stepped up to fill the gap left by the lack of significant financial providers in the marijuana industry. However, many dispensaries are still unfamiliar with the numerous alternatives to cash payments because they are content with the status quo, lack information or are constrained by their own antiquated systems.

A business faces many difficulties when it is a cash-only operation in terms of security, effectiveness, convenience and flexible channels of sale. By integrating payment technologies into their operations, dispensaries can lower cash payments by up to 30%, reducing the financial risks of theft and creating more time for employee-customer interaction.

Payment technologies not only enable more effective and safer transactions but also ease of operation and convenience, both of which have the potential to boost sales and, in some instances, double the average sale value. Cashless transactions make online ordering easier, which results in higher sales.

The most popular types of cash substitute payments available today are debit cards, cashless ATM transactions and ACH direct deposits.

Recently, however, ATM transactions faced outages because of the operation on the gap that allowed dispensaries to process transactions by mistaking ATM withdrawals as originating from a nearby location.

The crackdown prompted retailers to look into alternatives such as those provided by TreezPay, the first marijuana payment-processing solution to provide several digital payment options. According to the company, TreezPay’s cashless transaction options enable retailers to increase their monthly sales by more than 25%.

Treez obtained Swifter in 2022, an API transaction platform designed to deliver the particular requirements of the marijuana industry, in a bid to continue providing payment solutions. Swifter improves digital transactions by offering integrated, partner-powered services that increase stability, transparency and processing rates.

The API platform concentrates on integrating with as many other cutting-edge solutions as possible, such as mobile QR and cryptocurrency, while also providing a wide range of cannabis-focused solutions. This gives each dispensary the freedom to explore its options and create the software environment best suited to its requirements.

Ultimately, the industry isn’t expecting any financial-related legislation to support it anytime soon, according to cannatech companies. Thus, tech companies are proactively supplying sophisticated payment solutions that aid dispensaries in acquiring more clients, boosting sales, delivering superior customer service and managing significantly less cash.

As these payment-processing alternatives become widespread within the cannabis industry, it could have a beneficial ripple effect that may see ancillary enterprises such as Advanced Container Technologies Inc. (OTC: ACTX) gain additional traction as demand for marijuana products increases and subsequently supply ramps up in different markets.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.